Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 4/2008

01.07.2008 | Original Article

Role of a hepatectomy for the treatment of large hepatocellular carcinomas measuring 10 cm or larger in diameter

verfasst von: Kazuaki Shimada, Yoshihiro Sakamoto, Minoru Esaki, Tomoo Kosuge

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

A curative hepatectomy is the mainstay of effective treatment for small hepatocellular carcinoma (HCC), but the treatment of large HCC remains challenging.

Materials and methods

The possible prognostic factors were retrospectively analyzed in 85 patients with large HCC (≥10.0 cm) who all underwent a hepatectomy for HCC between 1988 and 2004. A survival analysis was made by classifying the tumors into four spreading patterns according to the number of tumors and the presence of macroscopic tumor thrombus.

Results

A positive hepatitis B antigen, the earlier period of hepatectomy, a non-curative hepatectomy, multiple tumors, and portal vein invasion were identified as independent predictors of a poor prognosis. The median survival term and 5-year survival rate of patients with a solitary large HCC without a macroscopic tumor thrombus was 9.8 years and 69.8%, respectively. The tumor spreading patterns according to the number of tumors and the presence of a macroscopic tumor thrombus were statistically associated with a non-curative hepatectomy (p < 0.001). There was a statistical difference among 33 patients with large HCC undergoing a non-curative hepatectomy based on the presence of a macroscopic portal vein invasion (p = 0.0089).

Conclusion

A hepatectomy could yield an excellent long-term survival in patients with a solitary large HCC without a macroscopic tumor thrombus. Even if a curative hepatectomy could not be achieved, a hepatectomy might provide better survival in large HCC patients without a macroscopic tumor thrombus compared in those with macroscopic tumor thrombus.
Literatur
1.
Zurück zum Zitat Poon RT, Fan ST, Lo CM, Liu CL, Wong J (2002) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235:373–382PubMedCrossRef Poon RT, Fan ST, Lo CM, Liu CL, Wong J (2002) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235:373–382PubMedCrossRef
2.
Zurück zum Zitat Lau WY, Leung TWT, Yu SCH, Ho SKW (2003) Percutaneous local ablative therapy for hepatocellular carcinoma. A review and look into the future. Ann Surg 237:171–179PubMedCrossRef Lau WY, Leung TWT, Yu SCH, Ho SKW (2003) Percutaneous local ablative therapy for hepatocellular carcinoma. A review and look into the future. Ann Surg 237:171–179PubMedCrossRef
3.
Zurück zum Zitat Mazzaferro V, Regalia E, Doci R, Castaing D, Diamond T, Dennison A (1996) N Engl J Med 334:693–699PubMedCrossRef Mazzaferro V, Regalia E, Doci R, Castaing D, Diamond T, Dennison A (1996) N Engl J Med 334:693–699PubMedCrossRef
4.
Zurück zum Zitat Takayasu K, Arii S, Ikai I et al (2006) Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131:461–469PubMedCrossRef Takayasu K, Arii S, Ikai I et al (2006) Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131:461–469PubMedCrossRef
5.
Zurück zum Zitat Poon RT, Fun ST, Wong J (2002) Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll Surg 194:592–602PubMedCrossRef Poon RT, Fun ST, Wong J (2002) Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll Surg 194:592–602PubMedCrossRef
6.
Zurück zum Zitat Hanazaki K, Kajikawa S, Shimozawa N et al (2002) Hepatic resection for hepatocellular carcinoma in diameter of ≥10 cm. Hepatogastroenterology 49:518–523PubMed Hanazaki K, Kajikawa S, Shimozawa N et al (2002) Hepatic resection for hepatocellular carcinoma in diameter of ≥10 cm. Hepatogastroenterology 49:518–523PubMed
7.
Zurück zum Zitat Yeh CN, Lee WC, Chen MF (2003) Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: two decades of experience at Chang Gung Memorial Hospital. Ann Surg Oncol 10:1070–1076PubMedCrossRef Yeh CN, Lee WC, Chen MF (2003) Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: two decades of experience at Chang Gung Memorial Hospital. Ann Surg Oncol 10:1070–1076PubMedCrossRef
8.
Zurück zum Zitat Nagano Y, Tanaka K, Togo S et al (2005) Efficacy of hepatic resection for hepatocellular carcinoma larger than 10 cm. World J Surg 29:66–71PubMedCrossRef Nagano Y, Tanaka K, Togo S et al (2005) Efficacy of hepatic resection for hepatocellular carcinoma larger than 10 cm. World J Surg 29:66–71PubMedCrossRef
9.
Zurück zum Zitat Liau KH, Ruo L, Shia J et al (2005) Outcome of partial hepatectomy for large (>10 cm) hepatocellular carcinoma. Cancer 104:1948–1955PubMedCrossRef Liau KH, Ruo L, Shia J et al (2005) Outcome of partial hepatectomy for large (>10 cm) hepatocellular carcinoma. Cancer 104:1948–1955PubMedCrossRef
10.
Zurück zum Zitat Ikai I, Yamaoka Y, Yamamoto Y et al (1998) Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastases. Proposal as a standard therapy. Ann Surg 277:433–439CrossRef Ikai I, Yamaoka Y, Yamamoto Y et al (1998) Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastases. Proposal as a standard therapy. Ann Surg 277:433–439CrossRef
11.
Zurück zum Zitat Liver Cancer Study Group of Japan (1997) Classification of primary liver cancer (English edition). Kanehara & Co, Ltd, Tokyo Liver Cancer Study Group of Japan (1997) Classification of primary liver cancer (English edition). Kanehara & Co, Ltd, Tokyo
12.
Zurück zum Zitat O’Suilleabhain CB, Poon RT, Yong JL, Ooi GC, Tso WK, Fan ST (2003) Factors predictive of 5-year survival after transarterial chemoembolization for inoperative hepatocellular carcinoma. Br J Surg 90:325–331PubMedCrossRef O’Suilleabhain CB, Poon RT, Yong JL, Ooi GC, Tso WK, Fan ST (2003) Factors predictive of 5-year survival after transarterial chemoembolization for inoperative hepatocellular carcinoma. Br J Surg 90:325–331PubMedCrossRef
13.
Zurück zum Zitat Taura K, Ikai I, Hatano E, Fujii H, Uyama N, Shimahara Y (2006) Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection. An analysis of 610 patients over 16 years old. Ann Surg 244:265–273PubMedCrossRef Taura K, Ikai I, Hatano E, Fujii H, Uyama N, Shimahara Y (2006) Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection. An analysis of 610 patients over 16 years old. Ann Surg 244:265–273PubMedCrossRef
14.
Zurück zum Zitat Matsui O, Kadoya M, Yoshikawa J et al (2003) Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 188:79–83 Matsui O, Kadoya M, Yoshikawa J et al (2003) Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 188:79–83
15.
Zurück zum Zitat Shiratori Y, Shiina S, Imamura M et al (1995) Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology 22:1027–1033PubMedCrossRef Shiratori Y, Shiina S, Imamura M et al (1995) Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology 22:1027–1033PubMedCrossRef
16.
Zurück zum Zitat Shirabe K, Shimada M, Kajiyama K et al (1998) Clinicopathologic features of patients with hepatocellular carcinoma surviving >10 years after hepatic resection. Cancer 83:2312–2316PubMedCrossRef Shirabe K, Shimada M, Kajiyama K et al (1998) Clinicopathologic features of patients with hepatocellular carcinoma surviving >10 years after hepatic resection. Cancer 83:2312–2316PubMedCrossRef
17.
Zurück zum Zitat Wu CC, Ho YZ, Ho WL et al (1995) Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg 82:122–126PubMedCrossRef Wu CC, Ho YZ, Ho WL et al (1995) Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg 82:122–126PubMedCrossRef
Metadaten
Titel
Role of a hepatectomy for the treatment of large hepatocellular carcinomas measuring 10 cm or larger in diameter
verfasst von
Kazuaki Shimada
Yoshihiro Sakamoto
Minoru Esaki
Tomoo Kosuge
Publikationsdatum
01.07.2008
Verlag
Springer-Verlag
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 4/2008
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-007-0264-4

Weitere Artikel der Ausgabe 4/2008

Langenbeck's Archives of Surgery 4/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.